Re: BEWARE!!! FDA grants priority review to Wyeth infant vaccine

[Guest guest]

great so are we going to vaccinate this to adults of kids, cause I bet if

it gets passed our kids get them. notice they aren't testing them on kids!

Original Message:

-----------------

From: a DeVelbiss gabrieladevelbiss@...

Date: Sat, 9 May 2009 10:34:06 -0700 (PDT)

To: StemCell_for_Autism2 ,

AUTISM-togetherinautismorg ,

alternative-autismhealing , gfcfrecipes ,

GAPShelp , india_developmentaldisabilities ,

childrensapraxianet , chelatingkids2 ,

myelinsheathprotein , glyco_powered ,

tracyautismparentsgroup , mb12 valtrex ,

valleysnafu

Subject: BEWARE!!! FDA grants priority review to Wyeth infant

vaccine

http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

 

Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

Wyeth ( WYE - news - people ) submitted an application to the U.S. Food and

Drug Administration on March 31.

 

Prevnar, on the market since 2000, currently protects against seven of the

most common strains of a strep bacteria, Streptococcus pneumoniae. The

bacteria can cause ear infections, pneumonia and more-dangerous, invasive

conditions including bloodstream infections and meningitis.

The new version, called Prevnar 13, protects against those strains, plus

six others - the next-most common ones - that cause the same diseases.

A priority review is given to products that, if approved, would represent

" a significant therapeutic or public health advance, " Wyeth said in a

statement.

 

Wyeth also has been testing the vaccine in adults and expects next year to

apply for approval to market Prevnar 13 for them.

Prevnar registered $2.7 billion in sales last year and $755 million in the

first quarter this year.

Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth in

deal worth $68 billion when announced. The deal is expected to close later

this year.

 

Love, Gabby. :0)

http://stemcellforautism.blogspot.com/

 

" I know of nobody who is purely Autistic or purely neurotypical. Even God

had some Autistic moments, which is why the planets all spin. " ~ Jerry

Newport

 

 

--------------------------------------------------------------------

mail2web.com – What can On Demand Business Solutions do for you?

http://link.mail2web.com/Business/SharePoint

[Guest guest]

great so are we going to vaccinate this to adults of kids, cause I bet if

it gets passed our kids get them. notice they aren't testing them on kids!

Original Message:

-----------------

From: a DeVelbiss gabrieladevelbiss@...

Date: Sat, 9 May 2009 10:34:06 -0700 (PDT)

To: StemCell_for_Autism2 ,

AUTISM-togetherinautismorg ,

alternative-autismhealing , gfcfrecipes ,

GAPShelp , india_developmentaldisabilities ,

childrensapraxianet , chelatingkids2 ,

myelinsheathprotein , glyco_powered ,

tracyautismparentsgroup , mb12 valtrex ,

valleysnafu

Subject: BEWARE!!! FDA grants priority review to Wyeth infant

vaccine

http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

 

Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

Wyeth ( WYE - news - people ) submitted an application to the U.S. Food and

Drug Administration on March 31.

 

Prevnar, on the market since 2000, currently protects against seven of the

most common strains of a strep bacteria, Streptococcus pneumoniae. The

bacteria can cause ear infections, pneumonia and more-dangerous, invasive

conditions including bloodstream infections and meningitis.

The new version, called Prevnar 13, protects against those strains, plus

six others - the next-most common ones - that cause the same diseases.

A priority review is given to products that, if approved, would represent

" a significant therapeutic or public health advance, " Wyeth said in a

statement.

 

Wyeth also has been testing the vaccine in adults and expects next year to

apply for approval to market Prevnar 13 for them.

Prevnar registered $2.7 billion in sales last year and $755 million in the

first quarter this year.

Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth in

deal worth $68 billion when announced. The deal is expected to close later

this year.

 

Love, Gabby. :0)

http://stemcellforautism.blogspot.com/

 

" I know of nobody who is purely Autistic or purely neurotypical. Even God

had some Autistic moments, which is why the planets all spin. " ~ Jerry

Newport

 

 

--------------------------------------------------------------------

mail2web.com – Enhanced email for the mobile individual based on Microsoft®

Exchange - http://link.mail2web.com/Personal/EnhancedEmail

[Guest guest]

A new version huh? Six years ago the " old version "

worked so well on my son's immune system that he

contracted strep 2 wks. after the shot (at 1 yr old)

and an ear infection 2 wks. after that - 1 year

later, mycoplasma bacteria off the charts and

two years later, strep 10 x the ref. range.. clinical

PANDAS symptoms, etc.

Yeah, Prevnar was just GREAT for my kid!

-- In mb12 valtrex , a DeVelbiss

wrote:

>

> http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

>  

> Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

> Wyeth ( WYE - news - people ) submitted an application to the U.S. Food and

Drug Administration on March 31.

>  

> Prevnar, on the market since 2000, currently protects against seven of the

most common strains of a strep bacteria, Streptococcus pneumoniae. The bacteria

can cause ear infections, pneumonia and more-dangerous, invasive conditions

including bloodstream infections and meningitis.

> The new version, called Prevnar 13, protects against those strains, plus six

others - the next-most common ones - that cause the same diseases.

> A priority review is given to products that, if approved, would represent " a

significant therapeutic or public health advance, " Wyeth said in a statement.

>  

> Wyeth also has been testing the vaccine in adults and expects next year to

apply for approval to market Prevnar 13 for them.

> Prevnar registered $2.7 billion in sales last year and $755 million in the

first quarter this year.

> Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth in

deal worth $68 billion when announced. The deal is expected to close later this

year.

>

>

>  

> Love, Gabby. :0)

> http://stemcellforautism.blogspot.com/

>  

> " I know of nobody who is purely Autistic or purely neurotypical. Even God had

some Autistic moments, which is why the planets all spin. " ~ Jerry Newport

>  

>  

>

[Guest guest]

yeah our story to, we reacted to the prevnar and ended up giving him RSV

for 8 months and he is a PANDAS nightmear, if only I had known then what I

know now

Original Message:

-----------------

From: recoveringty recoveringty@...

Date: Sat, 09 May 2009 21:15:01 -0000

To: mb12 valtrex

Subject: Re: BEWARE!!! FDA grants priority review to Wyeth

infant vaccine

A new version huh? Six years ago the " old version "

worked so well on my son's immune system that he

contracted strep 2 wks. after the shot (at 1 yr old)

and an ear infection 2 wks. after that - 1 year

later, mycoplasma bacteria off the charts and

two years later, strep 10 x the ref. range.. clinical

PANDAS symptoms, etc.

Yeah, Prevnar was just GREAT for my kid!

-- In mb12 valtrex , a DeVelbiss

wrote:

>

> http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

>  

> Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

> Wyeth ( WYE - news - people ) submitted an application to the U.S. Food

and Drug Administration on March 31.

>  

> Prevnar, on the market since 2000, currently protects against seven of

the most common strains of a strep bacteria, Streptococcus pneumoniae. The

bacteria can cause ear infections, pneumonia and more-dangerous, invasive

conditions including bloodstream infections and meningitis.

> The new version, called Prevnar 13, protects against those strains, plus

six others - the next-most common ones - that cause the same diseases.

> A priority review is given to products that, if approved, would represent

" a significant therapeutic or public health advance, " Wyeth said in a

statement.

>  

> Wyeth also has been testing the vaccine in adults and expects next year

to apply for approval to market Prevnar 13 for them.

> Prevnar registered $2.7 billion in sales last year and $755 million in

the first quarter this year.

> Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth

in deal worth $68 billion when announced. The deal is expected to close

later this year.

>

>

>  

> Love, Gabby. :0)

> http://stemcellforautism.blogspot.com/

>  

> " I know of nobody who is purely Autistic or purely neurotypical. Even God

had some Autistic moments, which is why the planets all spin. " ~ Jerry

Newport

>  

>  

>

--------------------------------------------------------------------

mail2web.com – Enhanced email for the mobile individual based on Microsoft®

Exchange - http://link.mail2web.com/Personal/EnhancedEmail

[Guest guest]

yeah our story to, we reacted to the prevnar and ended up giving him RSV

for 8 months and he is a PANDAS nightmear, if only I had known then what I

know now

Original Message:

-----------------

From: recoveringty recoveringty@...

Date: Sat, 09 May 2009 21:15:01 -0000

To: mb12 valtrex

Subject: Re: BEWARE!!! FDA grants priority review to Wyeth

infant vaccine

A new version huh? Six years ago the " old version "

worked so well on my son's immune system that he

contracted strep 2 wks. after the shot (at 1 yr old)

and an ear infection 2 wks. after that - 1 year

later, mycoplasma bacteria off the charts and

two years later, strep 10 x the ref. range.. clinical

PANDAS symptoms, etc.

Yeah, Prevnar was just GREAT for my kid!

-- In mb12 valtrex , a DeVelbiss

wrote:

>

> http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

>  

> Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

> Wyeth ( WYE - news - people ) submitted an application to the U.S. Food

and Drug Administration on March 31.

>  

> Prevnar, on the market since 2000, currently protects against seven of

the most common strains of a strep bacteria, Streptococcus pneumoniae. The

bacteria can cause ear infections, pneumonia and more-dangerous, invasive

conditions including bloodstream infections and meningitis.

> The new version, called Prevnar 13, protects against those strains, plus

six others - the next-most common ones - that cause the same diseases.

> A priority review is given to products that, if approved, would represent

" a significant therapeutic or public health advance, " Wyeth said in a

statement.

>  

> Wyeth also has been testing the vaccine in adults and expects next year

to apply for approval to market Prevnar 13 for them.

> Prevnar registered $2.7 billion in sales last year and $755 million in

the first quarter this year.

> Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth

in deal worth $68 billion when announced. The deal is expected to close

later this year.

>

>

>  

> Love, Gabby. :0)

> http://stemcellforautism.blogspot.com/

>  

> " I know of nobody who is purely Autistic or purely neurotypical. Even God

had some Autistic moments, which is why the planets all spin. " ~ Jerry

Newport

>  

>  

>

--------------------------------------------------------------------

myhosting.com - Premium Microsoft® Windows® and Linux web and application

hosting - http://link.myhosting.com/myhosting

[Guest guest]

What I wouldn't give sometimes to go back to the one fateful doctor's visit...

>

>

> yeah our story to, we reacted to the prevnar and ended up giving him RSV

> for 8 months and he is a PANDAS nightmear, if only I had known then what I

> know now

[Guest guest]

Yeah, *SLAP*

> >

> >

> > yeah our story to, we reacted to the prevnar and ended up giving him RSV

> > for 8 months and he is a PANDAS nightmear, if only I had known then what I

> > know now

>

[Guest guest]

Prevnar, oh, you mean the SIDS vaccine?

I'm almost nervous having my kids in public schools, I mean, they were doing

studies on vaccinating via food (cereal, actually). I don't even like it when

the dentists come to school, I am afraid they'll give my kids fluoride. I just

tell people NO FOOD for them, they have allergies, I provide everything!

>

> http://www.forbes.com/feeds/ap/2009/05/07/ap6391498.html

>  

> Drug maker Wyeth said Thursday federal regulators have granted a priority

review to a new version of its blockbuster infant vaccine Prevnar, and the

company expects a regulatory decision within six months.

> Wyeth ( WYE - news - people ) submitted an application to the U.S. Food and

Drug Administration on March 31.

>  

> Prevnar, on the market since 2000, currently protects against seven of the

most common strains of a strep bacteria, Streptococcus pneumoniae. The bacteria

can cause ear infections, pneumonia and more-dangerous, invasive conditions

including bloodstream infections and meningitis.

> The new version, called Prevnar 13, protects against those strains, plus six

others - the next-most common ones - that cause the same diseases.

> A priority review is given to products that, if approved, would represent " a

significant therapeutic or public health advance, " Wyeth said in a statement.

>  

> Wyeth also has been testing the vaccine in adults and expects next year to

apply for approval to market Prevnar 13 for them.

> Prevnar registered $2.7 billion in sales last year and $755 million in the

first quarter this year.

> Drug making giant Pfizer Inc. ( PFE - news - people ) is acquiring Wyeth in

deal worth $68 billion when announced. The deal is expected to close later this

year.

>

>

>  

> Love, Gabby. :0)

> http://stemcellforautism.blogspot.com/

>  

> " I know of nobody who is purely Autistic or purely neurotypical. Even God had

some Autistic moments, which is why the planets all spin. " ~ Jerry Newport

>  

>  

>

[Guest guest]

My Pediatrician was " out of the MMR " the day my

son reacted to the varicella, prevnar and HIB -

while I would love " to go back " , I do thank God

for small blessings!

> >

> >

> > yeah our story to, we reacted to the prevnar and ended up giving him RSV

> > for 8 months and he is a PANDAS nightmear, if only I had known then what I

> > know now

>